Intrasense wins EU CE mark for DUOnco Unity oncology CT AI software

• Intrasense secured CE marking under EU MDR 2017/745 for DUOnco Unity, an AI tool supporting oncology follow-up on CT scans.
• The software combines automated lesion detection, segmentation, and longitudinal tracking across chest-abdomen-pelvis scans within one certified device.
• Development was backed by Bpifrance, with Guerbet, Gustave Roussy, and Angers University Hospital as partners.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Intrasense SA published the original content used to generate this news brief on August 20, 2026, and is solely responsible for the information contained therein.